• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.

作者信息

Manno Girolamo, Novo Giuseppina, Corrado Egle, Coppola Giuseppe, Novo Salvatore

机构信息

Department of Emergency and Urgency, Biomedic Department of Internal Medicine and Specialities (DIBIMIS).

Chair and Post/Graduate School of Cardiovascular Diseases, Department for Promoting Health (PROSAMI), Division of Cardiology, University Hospital 'Paolo Giaccone' of Palermo, Palermo, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):403-405. doi: 10.2459/JCM.0000000000000752.

DOI:10.2459/JCM.0000000000000752
PMID:30762659
Abstract
摘要

相似文献

1
Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.直接口服抗凝剂在高龄患者中的应用：阿哌沙班用于一位百岁以上患者的病例报告
J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):403-405. doi: 10.2459/JCM.0000000000000752.
2
Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixaban.老年房颤患者服用低剂量阿哌沙班时阿哌沙班高血药浓度的预测因素。
Eur J Clin Pharmacol. 2021 Nov;77(11):1757-1758. doi: 10.1007/s00228-021-03135-8. Epub 2021 May 20.
3
Acquired Hemophilia A in an Elderly Patient on Apixaban Therapy.接受阿哌沙班治疗的老年患者获得性甲型血友病
Isr Med Assoc J. 2021 Feb;23(2):130-131.
4
Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.法国非瓣膜性心房颤动患者中阿哌沙班预防卒中和全身性栓塞：PAROS 横断面研究的原理和设计。
Arch Cardiovasc Dis. 2018 May;111(5):349-356. doi: 10.1016/j.acvd.2017.07.005. Epub 2017 Nov 27.
5
Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.阿哌沙班治疗患者的特征、规定剂量评估及治疗持续性：加泰罗尼亚的一项队列研究
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):494-501. doi: 10.1177/1074248418778544. Epub 2018 May 23.
6
Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.接受心房颤动消融术患者使用阿哌沙班、利伐沙班和达比加群的情况。
J Cardiovasc Electrophysiol. 2016 Feb;27(2):147-53. doi: 10.1111/jce.12856. Epub 2015 Nov 23.
7
Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.冠状动脉旁路移植术后心房颤动抗凝治疗的比较：一项初步研究。
J Cardiovasc Pharmacol Ther. 2020 Nov;25(6):523-530. doi: 10.1177/1074248420929483. Epub 2020 Jun 1.
8
Critical appraisal of the AUGUSTUS trial.对AUGUSTUS试验的批判性评价。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):187-188. doi: 10.1093/ehjcvp/pvz017.
9
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.AXAFA-AFNET 5研究的原理与设计：一项由研究者发起的、随机、开放、盲法终点评估的多中心试验，旨在比较房颤导管消融患者中持续使用阿哌沙班与维生素K拮抗剂的疗效。
Europace. 2017 Jan;19(1):132-138. doi: 10.1093/europace/euw368.
10
A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption.使用阿哌沙班出现的一种罕见副作用：掌跖部银屑病样药疹。
Anatol J Cardiol. 2016 Mar;16(3):213-5. doi: 10.14744/AnatolJCardiol.2016.6774.

引用本文的文献

1
Failure of non-vitamin K antagonist oral anticoagulants in preventing stroke in elderly patient: a case report of multiple strokes on standard of care treatment for atrial fibrillation.非维生素K拮抗剂口服抗凝药在预防老年患者卒中方面的失败：1例房颤标准治疗下多次卒中的病例报告
Arch Clin Cases. 2021 Oct 27;8(1):1-6. doi: 10.22551/2021.30.0801.10177. eCollection 2021.
2
Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion.心房颤动患者电复律时直接口服抗凝剂的管理。
Medicina (Kaunas). 2019 Sep 30;55(10):660. doi: 10.3390/medicina55100660.